Ledifos Tablets contains Ledipasvir and Sofosbuvir a formulation combination of anti-viral medications used in the treatment of Chronic Hepatitis C Virus (CHC) infection genotype 1. Ledifos is a prescription medicine containing Ledipasvir (90mg) a viral NS5A inhibitor and Sofosbuvir (400mg) a nucleotide inhibitor of the viral RNA polymerase.
The international brand name of this medicine is that provides effective treatment in Chronic Hepatitis C Genotype 1 with a cure rate ranging between 94% to 99%. Ledifos helps prevent Chronic Hepatitis C Virus infection from multiplying in your body by weakening the virus and inhibiting its reproduction and replication.
Ledifos is to be administered under the strict supervision of a Hepatologist only.
* Ledifos is to be taken by adults over 18 years of age only.
* Ledifos is to be taken orally with a full glass of water.
* The maximum recommended dosing frequency is once per day.
* To be taken at the same time every day (24 hour gap).
* Ledifos’s length of treatment may vary for a period between 8 weeks to 24 weeks.
* Do not stop use and intake of other anti-viral medications alongside Ledifos unless instructed by your doctor.
Important Information for Ledifos :-
The correct dosage and prescription commonly depend on the patient and the condition being treated. Duration of dosage can range between 8 weeks to 24 weeks and the correct duration of treatment is to be determined by your medical practitioner or doctor as it will depend on the patient’s condition and their response to the therapy. Do not adjust your dosage without the approval of your medical practitioner or doctor. This product is only for use as prescribed and instructed by a doctor or medical practitioner.Most people will be given a dose of a single pill each day for a period of 8-12 weeks. Your doctor may prescribe you a different dosage. Follow your doctor’s instructions.
is a prescription drug and should be used under proper medical guidance and advice.The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.(Ledipasvir/Sofobuvir) has a very high cure rate and is an ideal treatment for most hepatitis C patients. There are however, some situations where you should not take Ledifos. Do not take Ledifos if you have an allergy to the active ingredients (ledipasvir or sofosbuvir) Do not take Ledifos if you are already taking another any other medicine that contains sofosbuvir . Do not take if you are on any medicines that contains cobicistat, elvitegravir, emtricitabine, tenofovir, carbamazepine, oxcarbazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentine, rosuvastatin, simeprevir, St. John’s wort, tipranavir or ritonavir (ledifos suppliers dealers India) Some other conditions should also be made known to your doctor. They will not necessarily stop you from taking it, but you may need to be monitored closely.
Other details on LediFos:-
- Ledifos is indicated for the treatment of patients with chronic (HCV) genotype 1, 4, 5, or 6 infection.
- Ledifos is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration.